Literature DB >> 19171231

[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].

L Gressier1, C Pruvost-Balland, L Dubertret, M Viguier.   

Abstract

BACKGROUND: Atorvastatin is a widely-used therapeutic statin given for hypercholesterolaemia and for prevention of cardiovascular events. We report herein the occurrence of a drug reaction with eosinophilia and systemic symptoms (DRESS) secondary to intake of this drug. CASE REPORT: A 58-year-old woman presented with a febrile skin rash and facial oedema, appearing 6weeks after the start of atorvastatin for dyslipidaemia. The clinical features associated disseminated polymorphic lesions, oral mucosa involvement and systemic symptoms (fever, abdominal pain, diarrhoea, polyarthralgia and adenomegaly). Blood tests showed hypereosinophilia up to 11,540/mm(3), inflammatory syndrome and anicteric cholestasis without cytolysis. Serological tests for hepatitis B and C, HIV, EBV, HHV-6, HHV-8, CMV and human Parvovirus B-19 were negative. Cutaneous histology was unspecific. A diagnosis of DRESS secondary to atorvastatin was suspected. The clinical outcome was favourable after atorvastatin discontinuation. DISCUSSION: To our knowledge, this is the first description of atorvastatin inducing DRESS, a severe life-threatening drug eruption. Atorvastatin has previously been implicated in various cutaneous adverse events. Because of their potentially serious side effects, prescription of statins must be carefully evaluated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19171231     DOI: 10.1016/j.annder.2008.07.063

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  7 in total

1.  Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin.

Authors:  Theodoros Kelesidis; Iosif Kelesidis
Journal:  Clin Ther       Date:  2009-12       Impact factor: 3.393

2.  A case of psoriasis worsened by atorvastatin.

Authors:  Emanuele Cozzani; Manuela Scaparro; Aurora Parodi
Journal:  J Dermatol Case Rep       Date:  2009-12-30

3.  Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system.

Authors:  Gabriela Mazzanti; Paola Angela Moro; Emanuel Raschi; Roberto Da Cas; Francesca Menniti-Ippolito
Journal:  Br J Clin Pharmacol       Date:  2017-01-19       Impact factor: 4.335

4.  Levetiracetam Induced Drug Reaction with Eosinophilia and Systemic Symptom Syndrome.

Authors:  Waseem Raja Dar; Najeebullah Sofi; Muzamil Latief; Imtiyaz Ahmad Dar; Basharat Ahmad Kasana
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

Review 5.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature.

Authors:  Jared James; Yasser M Sammour; Andrew R Virata; Terri A Nordin; Igor Dumic
Journal:  Am J Case Rep       Date:  2018-02-14

6.  The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials.

Authors:  Mateusz Socha; Aldona Pietrzak; Ewelina Grywalska; Daniel Pietrzak; Dariusz Matosiuk; Paweł Kiciński; Jacek Rolinski
Journal:  Arch Med Sci       Date:  2019-12-06       Impact factor: 3.318

7.  Characterization of chemically induced liver injuries using gene co-expression modules.

Authors:  Gregory J Tawa; Mohamed Diwan M AbdulHameed; Xueping Yu; Kamal Kumar; Danielle L Ippolito; John A Lewis; Jonathan D Stallings; Anders Wallqvist
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.